Form 4: Rhythm Pharmaceuticals CFO Hunter Smith Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Hunter Smith, CFO of Rhythm Pharmaceuticals, sold 15,515 shares of common stock on March 19, 2024, to cover withholding taxes related to vesting restricted stock units.
Summary
- On March 19, 2024, Hunter Smith, the Chief Financial Officer of Rhythm Pharmaceuticals, sold 15,515 shares of the company's common stock.
- The sale was executed at a weighted average price of $39.22 per share, with individual transactions ranging from $39.04 to $39.22.
- Following the transaction, Smith directly owns 97,939 shares of Rhythm Pharmaceuticals.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted before February 27, 2023, solely to cover withholding taxes associated with the vesting of previously reported restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral event. The sale is related to tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations related to stock-based compensation.
Key Dates
| Date | Description |
|---|---|
| 03/19/2024 | Date of the stock sale transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.